French health tech company Volta Medical, which developed an AI-enabled software for interventional cardiac electrophysiology, garnered €36 million ($37.8 million) in Series B funding, bringing its total raise to €70 million ($73.6 million).
U.S.-based Vensana Capital led the round, with co-investment from Lightstone Ventures and Glide Healthcare.
Volta offers its FDA-cleared XV1 AI-enabled...
